BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23447383)

  • 41. Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling.
    Bergé M; Allanic D; Bonnin P; de Montrion C; Richard J; Suc M; Boivin JF; Contrerès JO; Lockhart BP; Pocard M; Lévy BI; Tucker GC; Tobelem G; Merkulova-Rainon T
    J Hepatol; 2011 Oct; 55(4):866-75. PubMed ID: 21338642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling.
    Shintani Y; Takashima S; Asano Y; Kato H; Liao Y; Yamazaki S; Tsukamoto O; Seguchi O; Yamamoto H; Fukushima T; Sugahara K; Kitakaze M; Hori M
    EMBO J; 2006 Jul; 25(13):3045-55. PubMed ID: 16763549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.
    Fantin A; Herzog B; Mahmoud M; Yamaji M; Plein A; Denti L; Ruhrberg C; Zachary I
    Development; 2014 Feb; 141(3):556-62. PubMed ID: 24401374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropilin-1 Is Expressed on Lymphoid Tissue Residing LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic Lymphoid Aggregates.
    Shikhagaie MM; Björklund ÅK; Mjösberg J; Erjefält JS; Cornelissen AS; Ros XR; Bal SM; Koning JJ; Mebius RE; Mori M; Bruchard M; Blom B; Spits H
    Cell Rep; 2017 Feb; 18(7):1761-1773. PubMed ID: 28199847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thalidomide regulation of NF-κB proteins limits Tregs activity in chronic lymphocytic leukemia.
    Skórka K; Bhattacharya N; Własiuk P; Kowal M; Mertens D; Dmoszyńska A; Giannopoulos K
    Adv Clin Exp Med; 2014; 23(1):25-32. PubMed ID: 24596000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
    Chaudhary B; Elkord E
    Expert Opin Ther Targets; 2015 Feb; 19(2):147-61. PubMed ID: 25351619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells.
    Lu L; Zhang L; Xiao Z; Lu S; Yang R; Han ZC
    Leuk Lymphoma; 2008 Feb; 49(2):331-8. PubMed ID: 18231921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-γ Drives T
    Overacre-Delgoffe AE; Chikina M; Dadey RE; Yano H; Brunazzi EA; Shayan G; Horne W; Moskovitz JM; Kolls JK; Sander C; Shuai Y; Normolle DP; Kirkwood JM; Ferris RL; Delgoffe GM; Bruno TC; Workman CJ; Vignali DAA
    Cell; 2017 Jun; 169(6):1130-1141.e11. PubMed ID: 28552348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction.
    Jarvis A; Allerston CK; Jia H; Herzog B; Garza-Garcia A; Winfield N; Ellard K; Aqil R; Lynch R; Chapman C; Hartzoulakis B; Nally J; Stewart M; Cheng L; Menon M; Tickner M; Djordjevic S; Driscoll PC; Zachary I; Selwood DL
    J Med Chem; 2010 Mar; 53(5):2215-26. PubMed ID: 20151671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model.
    Mac Gabhann F; Popel AS
    Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2851-60. PubMed ID: 15708957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased
    Giri PS; Bharti AH; Dwivedi M
    J Immunol Res; 2022; 2022():3426717. PubMed ID: 36157881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor.
    Wang L; Zhou Y; Yin J; Gan Y; Wang X; Wen D; Thomson AW; Hu X; Yang L; Stetler RA; Li P; Yu W
    Stroke; 2018 Nov; 49(11):2733-2742. PubMed ID: 30355201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis.
    Song Y; Zeng S; Zheng G; Chen D; Li P; Yang M; Luo K; Yin J; Gu Y; Zhang Z; Jia X; Qiu N; He Z; Li H; Liu H
    Oncogene; 2021 Jan; 40(4):777-790. PubMed ID: 33262463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuropilin-1 in the immune system.
    Romeo PH; Lemarchandel V; Tordjman R
    Adv Exp Med Biol; 2002; 515():49-54. PubMed ID: 12613542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2.
    Vales A; Kondo R; Aichberger KJ; Mayerhofer M; Kainz B; Sperr WR; Sillaber C; Jäger U; Valent P
    Leuk Lymphoma; 2007 Oct; 48(10):1997-2007. PubMed ID: 17917967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropilin-1 is present on Foxp3+ T regulatory cell-derived small extracellular vesicles and mediates immunity against skin transplantation.
    Campos-Mora M; De Solminihac J; Rojas C; Padilla C; Kurte M; Pacheco R; Kaehne T; Wyneken Ú; Pino-Lagos K
    J Extracell Vesicles; 2022 Jun; 11(6):e12237. PubMed ID: 35676234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.
    Chuckran CA; Cillo AR; Moskovitz J; Overacre-Delgoffe A; Somasundaram AS; Shan F; Magnon GC; Kunning SR; Abecassis I; Zureikat AH; Luketich J; Pennathur A; Sembrat J; Rojas M; Merrick DT; Taylor SE; Orr B; Modugno F; Buckanovich R; Schoen RE; Kim S; Duvvuri U; Zeh H; Edwards R; Kirkwood JM; Coffman L; Ferris RL; Bruno TC; Vignali DAA
    Sci Transl Med; 2021 Dec; 13(623):eabf8495. PubMed ID: 34878821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.
    Jia H; Cheng L; Tickner M; Bagherzadeh A; Selwood D; Zachary I
    Br J Cancer; 2010 Feb; 102(3):541-52. PubMed ID: 20087344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.
    Mota F; Yelland T; Hutton JA; Parker J; Patsiarika A; Chan AWE; O'Leary A; Fotinou C; Martin JF; Zachary IC; Djordjevic S; Frankel P; Selwood DL
    Chembiochem; 2022 Jan; 23(1):e202100463. PubMed ID: 34647407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells.
    Powell J; Mota F; Steadman D; Soudy C; Miyauchi JT; Crosby S; Jarvis A; Reisinger T; Winfield N; Evans G; Finniear A; Yelland T; Chou YT; Chan AWE; O'Leary A; Cheng L; Liu D; Fotinou C; Milagre C; Martin JF; Jia H; Frankel P; Djordjevic S; Tsirka SE; Zachary IC; Selwood DL
    J Med Chem; 2018 May; 61(9):4135-4154. PubMed ID: 29648813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.